6533b81ffe1ef96bd1277c99
RESEARCH PRODUCT
MicroRNAs Associated With Biological Pathways of Left- and Right-sided Colorectal Cancer.
Jaana M. HartikainenVeli-matti KosmaJukka-pekka MecklinSami HeikkinenStralina EnehTeijo KuopioArto Mannermaasubject
False discovery rateOncologyMaleCancer Researchmedicine.medical_specialtyColorectal cancerDown-RegulationBiological pathwayCohort StudiesPhosphatidylinositol 3-KinasesTransforming Growth Factor betaInternal medicinemicroRNAMedicineHumansDifferential expressionPI3K/AKT/mTOR pathwayAgedbusiness.industryWnt signaling pathwayGeneral Medicinemedicine.diseasedigestive system diseasesUp-RegulationGene Expression Regulation NeoplasticOncologyCohortFemalebusinessColorectal NeoplasmsProto-Oncogene Proteins c-aktSignal Transductiondescription
BACKGROUND/AIM MicroRNAs (miRNAs) regulate the development of colorectal cancer (CRC). We aimed to investigate miRNAs and their relation to cancer-related signaling pathways in site-specific CRC. MATERIALS AND METHODS We used a total of 24 left- and right-sided Finnish CRC samples (discovery cohort) and The Cancer Genome Atlas public mature miRSeq dataset of 201 CRC samples (validation cohort). MiRNA differential expression and biological pathway analyses were performed using DESeq2 and the DIANA/mirPath tool, respectively. RESULTS We found 17 significantly differentially up-regulated [false discovery rate (FDR) <0.05] miRNAs in left-sided CRC ("left miRNAs"), and 15 in right-sided CRC ("right miRNAs"). The left miRNAs participate in the mTor, Wnt, PI3K-Akt signaling pathways (FDR<0.05). The right miRNAs participate in the TGF-β signaling pathway. We also observed that both cohorts share six miRNAs. One of these (hsa-miR-196b-5p) was significantly (FDR<0.05) up-regulated in left-sided CRC. The rest of them (hsa-miR-625-3p, hsa-miR-155-5p, hsa-miR-625-5p, hsa-miR-31-5p and hsa-miR-330-5p) showed significant (FDR<0.05) up-regulation in right-sided CRC. CONCLUSION Left and right miRNAs are associated with predominant biological pathways of left- and right-sided CRC, respectively. Our results may be beneficial for classifying CRC and for future biomarker studies of site-specific CRC.
year | journal | country | edition | language |
---|---|---|---|---|
2020-07-01 | Anticancer research |